Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in the UK Setting
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1874
https://www.valueinhealthjournal.com/article/S1098-3015(16)33240-5/fulltext
Title :
Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in the UK Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33240-5&doi=10.1016/j.jval.2016.09.1874
First page :
A672
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1770